NO20031844L - Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav - Google Patents

Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav

Info

Publication number: NO20031844L
Authority: NO; Norway
Prior art keywords: processes; preparation; ascorbic acid; acid compounds; new ascorbic
Prior art date: 2001-08-24

Application number

NO20031844A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031844D0 (no

Inventor

Matthias Rath

Original Assignee

Matthias Rath

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-24

Filing date

2003-04-24

Publication date

2003-06-12

2003-04-24 Application filed by Matthias Rath filed Critical Matthias Rath

2003-04-24 Publication of NO20031844D0 publication Critical patent/NO20031844D0/no

2003-06-12 Publication of NO20031844L publication Critical patent/NO20031844L/no

Links

125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

NO20031844A 2001-08-24 2003-04-24 Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav NO20031844L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US31485701P	2001-08-24	2001-08-24
PCT/EP2002/009451 WO2003018568A2 (fr)	2001-08-24	2002-08-23	Nouveaux composes d'acide ascorbique, leurs procedes de synthese et leur utilisation

Publications (2)

Publication Number	Publication Date
NO20031844D0 NO20031844D0 (no)	2003-04-24
NO20031844L true NO20031844L (no)	2003-06-12

Family

ID=23221754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031844A NO20031844L (no)	2001-08-24	2003-04-24	Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav

Country Status (19)

Country	Link
US (2)	US6864284B2 (fr)
EP (3)	EP2241559A3 (fr)
JP (1)	JP4162593B2 (fr)
KR (1)	KR20040044472A (fr)
CN (3)	CN100378087C (fr)
BR (1)	BR0205944A (fr)
CA (1)	CA2458344A1 (fr)
HR (1)	HRP20040207A2 (fr)
HU (1)	HUP0600084A2 (fr)
IL (4)	IL155578A0 (fr)
MX (1)	MXPA04001655A (fr)
NO (1)	NO20031844L (fr)
NZ (3)	NZ542240A (fr)
PL (1)	PL373522A1 (fr)
RU (1)	RU2309152C2 (fr)
UA (1)	UA78223C2 (fr)
WO (2)	WO2003018000A1 (fr)
YU (1)	YU38103A (fr)
ZA (1)	ZA200304712B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040067890A1 (en) *	2002-10-04	2004-04-08	Gupta Shyam K.	Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
AU2004232556A1 (en) *	2003-04-21	2004-11-04	Tagra Biotechnologies Ltd.	Stabilized derivatives of ascorbic acid
CN100346782C (zh) *	2004-05-21	2007-11-07	北京京卫信康医药科技发展有限公司	一种含氨基酸的维生素c组合物
KR100544159B1 (ko) *	2004-07-14	2006-01-24	센양 뉴라이프 인더스트리알 코 엘티디	아스코르빌 테트라이소팔미테이트와 디팔미토일하이드록시프롤린을 함유한 나노 에멀젼 및 이를함유하는 화장료 조성물
US20070002866A1 (en) *	2005-06-29	2007-01-04	Denso Corporation	Receive power priority flooding in mobile ad hoc networks
MX2008010716A (es)	2006-02-21	2008-10-14	Mary Kay Inc	Composiciones estables de vitamina c.
US20080188553A1 (en) *	2007-02-06	2008-08-07	Waheed M Roomi	Novel ascorbic acid compounds, methods of synthesis and application use thereof
FR2913686B1 (fr) *	2007-03-14	2009-05-01	Oreal	Nouveaux composes carbamates de vitamine c, compositions les comprenant, et utilisations
US8828960B2 (en) *	2007-07-17	2014-09-09	Idexx Laboratories, Inc.	Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
WO2018005762A2 (fr) *	2016-06-29	2018-01-04	Orasis Medical, Inc.	Conjugués acide ascorbique-acide aminé et leur utilisation dans la régulation d'écoulement de fluide
EP3682892A4 (fr) *	2017-09-15	2021-10-27	Kine Sciences Co., Ltd.	Utilisation de peptides en tant qu'agent thérapeutique contre des maladies auto-immunes et des maladies osseuses

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1273989A (fr) *	1960-09-09	1961-10-20	Marbou	Procédé de préparation de l'ascorbate de lysine
US4424232A (en) *	1982-05-19	1984-01-03	Parkinson Richard W	Treatment of herpes simplex
US4518614A (en) *	1982-11-04	1985-05-21	Redken Laboratories, Inc.	Cosmetic preparation
JPS63190882A (ja)	1987-02-03	1988-08-08	Nippon Haipotsukusu:Kk	アスコルビン酸誘導体及びそれを含有する皮膚脱色剤並びにその製造法
JP2973365B2 (ja) *	1988-09-19	1999-11-08	オクスィカル・ラボラトリーズ・インコーポレイテッド	治療学的に活性な化合物を投与するための組成物
FR2650180B1 (fr) *	1989-07-31	1995-03-03	Chisso Corp	Procede de production d'une feuille facilement soluble dans l'eau a base d'acide hyaluronique ou de hyaluronate et feuille ainsi obtenue
EP0532706B1 (fr) *	1990-06-04	1995-05-10	Health Now	REDUCTION D'OCCLUSIONS DE VAISSEAUX CARDIOVASCULAIRES A L'AIDE D'ASCORBATE ET D'INHIBITEURS DE LIAISON DE LA LIPOPROTEINE (a)
JPH04247011A (ja)	1991-02-04	1992-09-03	Q P Corp	リン脂質系アスコルビン酸誘導体及び該誘導体を含む皮膚外用剤
US5977073A (en) *	1991-06-06	1999-11-02	Life Sciences' Technologies, Inc.	Nutrient composition for treatment of immune disorders
JPH0666958A (ja) *	1991-08-29	1994-03-11	Masaki Yoshigaki	目覚し時計の目覚し設定並びに目覚し音停止機構
JPH0678560A (ja)	1992-08-26	1994-03-18	Matsushita Electric Works Ltd	インバータ装置
FR2715156B1 (fr)	1994-01-20	1996-03-01	Oreal	Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires.
US5626883A (en) *	1994-04-15	1997-05-06	Metagenics, Inc.	Ascorbic acid compositions providing enhanced human immune system activity
FR2732221B1 (fr) *	1995-03-28	1997-04-25	Oreal	Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US5951990A (en)	1995-05-15	1999-09-14	Avon Products, Inc.	Ascorbyl-phosphoryl-cholesterol
US5607968A (en)	1995-06-07	1997-03-04	Avon Products, Inc.	Topical alkyl-2-O-L-ascorbyl-phosphates
FR2737971B1 (fr)	1995-08-25	1997-11-14	Lvmh Rech	Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
US6162419A (en)	1996-11-26	2000-12-19	Nicholas V. Perricone	Stabilized ascorbyl compositions
US5962517A (en) *	1997-01-31	1999-10-05	Murad; Howard	Pharmaceutical compositions and methods for treating acne
EP0891771A1 (fr) *	1997-07-08	1999-01-20	Health Now, Inc.	Compositions comprenant du lysine et d'ascorbate ou ses dérivés pour le traitement de troubles cardiovasculaires

2002
- 2002-08-23 CA CA002458344A patent/CA2458344A1/fr not_active Abandoned
- 2002-08-23 WO PCT/US2002/027060 patent/WO2003018000A1/fr not_active Application Discontinuation
- 2002-08-23 ZA ZA200304712A patent/ZA200304712B/en unknown
- 2002-08-23 HU HU0600084A patent/HUP0600084A2/hu unknown
- 2002-08-23 IL IL15557802A patent/IL155578A0/xx not_active IP Right Cessation
- 2002-08-23 EP EP10006653.9A patent/EP2241559A3/fr not_active Withdrawn
- 2002-08-23 CN CNB2005101136870A patent/CN100378087C/zh not_active Expired - Fee Related
- 2002-08-23 NZ NZ542240A patent/NZ542240A/en unknown
- 2002-08-23 EP EP10006654.7A patent/EP2241560A3/fr not_active Withdrawn
- 2002-08-23 YU YU38103A patent/YU38103A/sh unknown
- 2002-08-23 US US10/226,588 patent/US6864284B2/en not_active Expired - Fee Related
- 2002-08-23 RU RU2004108687/04A patent/RU2309152C2/ru not_active IP Right Cessation
- 2002-08-23 WO PCT/EP2002/009451 patent/WO2003018568A2/fr active Application Filing
- 2002-08-23 BR BR0205944-4A patent/BR0205944A/pt not_active IP Right Cessation
- 2002-08-23 EP EP02772197A patent/EP1423375A2/fr not_active Withdrawn
- 2002-08-23 JP JP2003523231A patent/JP4162593B2/ja not_active Expired - Fee Related
- 2002-08-23 NZ NZ531430A patent/NZ531430A/en unknown
- 2002-08-23 NZ NZ542241A patent/NZ542241A/en unknown
- 2002-08-23 CN CNB2005101136885A patent/CN100361987C/zh not_active Expired - Fee Related
- 2002-08-23 KR KR10-2004-7002629A patent/KR20040044472A/ko not_active Ceased
- 2002-08-23 UA UA2004032169A patent/UA78223C2/uk unknown
- 2002-08-23 CN CNB028030184A patent/CN100360514C/zh not_active Expired - Fee Related
- 2002-08-23 PL PL02373522A patent/PL373522A1/xx unknown
- 2002-08-23 MX MXPA04001655A patent/MXPA04001655A/es active IP Right Grant
2003
- 2003-04-24 IL IL176524A patent/IL176524A0/en unknown
- 2003-04-24 NO NO20031844A patent/NO20031844L/no not_active Application Discontinuation
- 2003-04-24 IL IL155578A patent/IL155578A/en unknown
2004
- 2004-02-18 US US10/781,296 patent/US7230124B2/en not_active Expired - Fee Related
- 2004-03-02 HR HR20040207A patent/HRP20040207A2/hr not_active Application Discontinuation
2006
- 2006-06-22 IL IL176523A patent/IL176523A0/en unknown

Also Published As

Publication number	Publication date
RU2309152C2 (ru)	2007-10-27
UA78223C2 (uk)	2007-03-15
US20030119753A1 (en)	2003-06-26
CN1763028A (zh)	2006-04-26
NZ542240A (en)	2006-09-29
EP2241559A3 (fr)	2014-07-09
IL176524A0 (en)	2006-10-05
MXPA04001655A (es)	2004-05-31
BR0205944A (pt)	2004-12-28
US7230124B2 (en)	2007-06-12
NZ542241A (en)	2006-09-29
JP4162593B2 (ja)	2008-10-08
YU38103A (sh)	2006-05-25
EP2241560A2 (fr)	2010-10-20
WO2003018000A1 (fr)	2003-03-06
CN1763027A (zh)	2006-04-26
KR20040044472A (ko)	2004-05-28
HUP0600084A2 (en)	2006-06-28
CN100378087C (zh)	2008-04-02
EP1423375A2 (fr)	2004-06-02
CN100361987C (zh)	2008-01-16
IL155578A0 (en)	2003-11-23
WO2003018568A3 (fr)	2003-12-04
WO2003018568A2 (fr)	2003-03-06
CN100360514C (zh)	2008-01-09
US20040167077A1 (en)	2004-08-26
ZA200304712B (en)	2004-07-12
PL373522A1 (en)	2005-09-05
EP2241559A2 (fr)	2010-10-20
JP2005501867A (ja)	2005-01-20
CA2458344A1 (fr)	2003-03-06
NO20031844D0 (no)	2003-04-24
EP2241560A3 (fr)	2014-07-09
IL155578A (en)	2006-12-10
IL176523A0 (en)	2006-10-05
CN1518545A (zh)	2004-08-04
HRP20040207A2 (en)	2005-02-28
US6864284B2 (en)	2005-03-08
NZ531430A (en)	2006-05-26
RU2004108687A (ru)	2005-09-20

Legal Events

Date	Code	Title	Description
2009-03-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20015113D0 (no)	2001-10-19	Nye forbindelser, deres fremstilling og anvendelse
NO20040680L (no)	2004-02-16	Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20035428D0 (no)	2003-12-05	Nye anti-ineffektiver
NO20030301D0 (no)	2003-01-20	Nye heteroarylderivater og anvendelse derav som farmasöytika
DK1414809T3 (da)	2008-06-23	Indaneddikesyrederivater og anvendelse deraf som farmaceutiske midler, mellemprodukter og fremgangsmåder til fremstilling deraf
IS7188A (is)	2004-03-18	Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
NO20034992D0 (no)	2003-11-10	Nye 4-aninlinokinolin-3-karboksamider
NO20035325D0 (no)	2003-11-28	Hudpermeabelt selektiv cyklooksygenase-2-inhibitorpreparat
DK2206702T3 (da)	2012-02-13	Bicyklisk forbindelse, fremstilling og anvendelse deraf
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
NO20031273L (no)	2003-05-14	Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
NO20034970D0 (no)	2003-11-07	Nye arylheteroalkylaminderivater
NO20025029D0 (no)	2002-10-18	Nye epotilonderivater, fremgangsmåte for fremstilling derav og deres farmasöytiske anvendelse
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
IS7491A (is)	2004-10-06	Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DK1429769T3 (da)	2009-05-11	Nye formuleringer og anvendelse deraf
IL176523A0 (en)	2006-10-05	Ascorbic acid compounds, methods of synthesis and application use thereof
NO20043349L (no)	2004-10-05	Kumarinderivater, fremgangsmate for deres framstilling og anvendelse derav
DE60218213D1 (de)	2007-03-29	Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20035328D0 (no)	2003-11-28	Nye forbindelser og preparater som katepsinhibitorer
NO20052124D0 (no)	2005-04-29	Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
NO20041185L (no)	2004-03-19	Nye sykloheksylsulfoner
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir